• News

    Results Found: 26
    Thursday, May 13, 2021
    NCBIO is extremely disappointed that the Biden administration has chosen to support waiving critical intellectual property protections for U.S. COVID-19 vaccines. This decision, known as a TRIPS waiver, breaks faith with American innovators, punishes the ingenuity of our life sciences industry and will delay the equitable delivery of COVID vaccines to people around the globe.      Giving ...read more
    Categories: General News Article, Policy
    Wednesday, May 12, 2021
     One Week Until NCBIO Medical Device ForumWednesday, May 19 12:00 - 1:30 p.m.In one week, join NCBIO members and guests online for our Medical Device Forum to hear about life-saving technologies, still in various stages of development, that companies are attempting to guide through a process fraught with barriers in the best of times and now struggling against the immediacy of COVID. ...read more
    Categories: Advisory
    Monday, May 10, 2021
    REVIEW NCBIO Announces Upcoming Events and Webinars Upcoming Events and Webinars NCBIO's biweekly advisory highlighting upcoming events and webinars. Please monitor our events calendar for additional events.   Alcami Lab Open House Tuesday, May 11, at 11 a.m.   Investor Insights: Who They Fund and Why hosted by Hangar6 Tuesday, May 11, at 11:30 a.m.   Using Existing Data to ...read more
    Categories: Advisory
    Wednesday, April 28, 2021
     Register Now NCBIO Medical Device ForumWednesday, May 19 12:00 - 1:30 p.m.Join NCBIO members online for our Medical Device Forum on May 19. Although we are in a pandemic, patient needs continue unabated and often are made more dire by the intense focus on COVID that investments, regulatory bodies and government are taking. There are important life-saving technologies, still in ...read more
    Categories: Advisory
    Thursday, April 15, 2021
    Legislation that fixes prices for prescription medicines would limit patients’ access to new treatments while doing nothing to lower prices at the pharmacy counter, according to a new analysis released by NCBIO, the NC Biosciences Organization. The proposed law would also have a devastating effect on North Carolina’s innovative life sciences economy.  The study was commissioned by the Council for ...read more
    Categories: General News Article, Press Release, Policy
    Friday, March 26, 2021
    Like last year, this year’s Venture Connect held March 23-25 produced by the Council for Entrepreneurial Development took place entirely online but with many new features.   NCBIO is a sponsor of Venture Connect, which connects life science and technology companies in the Southeast with investors, sponsors and fellow entrepreneurs to network, discuss innovative technologies and foster ...read more
    Categories: General News Article
    Thursday, March 11, 2021
    Vol. 167WASHINGTON, THURSDAY, MARCH 4, 2021No. 41Senate REMEMBERING SAM TAYLOR Mr. Tillis. Madam President, I rise today with my colleague, the senior Senator from North Carolina, to honor the life and work of Sam Taylor, the president of North Carolina Biosciences Organization. Sam was a giant in our State and a leading voice for our vital and innovative life sciences and biopharmaceutical ...read more
    Categories: General News Article
    Tuesday, March 02, 2021
    NCBIO manufacturing companies discussed their workforce needs with North Carolina state legislators during the quarterly meeting of the NCBIO Biomanufacturers Forum held online Tuesday, March 2.   Representatives of Biogen, FUJIFILM DioSynth, Grifols, Merck, Novartis, Novozymes and Pfizer were among those who spoke to leaders of the NC General Assembly’s Life Sciences Caucus. Caucus co-chairs ...read more
    Categories: General News Article
    Thursday, February 25, 2021
    On Wednesday, Feb. 24, NCBIO hosted a webinar on “New Dynamics in Talent Recruitment” as part of the NCBIO Life Sciences Forums. Panelists discussed the challenges and opportunities that have arisen in recruiting and retaining employees during the pandemic.   Stephen Williams, practice lead, North Carolina sciences at Aerotek, served as moderator of a panel comprising Andrew Herdman, Ph.D., vice ...read more
    Categories: General News Article
    Thursday, February 25, 2021
    The latest industry and member news from NCBIO, your NC Biosciences Organization. March 2021 Update Serving the NC Life Sciences Industry ncbioscience.net 919.281.8960 NCBIO This MonthRemembering NCBIO President Sam TaylorFormer NCBIO board member, Biogen exec named NC commerce secretaryLegislative updateBIO's 100 Days of InnovationVaccines for essential workersCED Venture Connect 2021New NCI ...read more
    Categories: Newsletter--Connections
    Tuesday, February 23, 2021
    Sam Taylor, an unflagging advocate for North Carolina and its biosciences industry as president of NCBIO, died Sunday, Feb. 21, at the age of 64 of pancreatic cancer. His colleagues, collaborators and friends wrote to share their thoughts and feelings about him. "As champion of economic development through the life sciences, including small business, Sam Taylor was a tremendous leader, tireless ...read more
    Categories: General News Article
    Sunday, February 21, 2021
    Sam Taylor, an unflagging advocate for North Carolina and its biosciences industry as president of NCBIO, died Sunday, Feb. 21, at the age of 64 of pancreatic cancer. Taylor was best known for his success in driving the state’s life sciences industry to become one of the largest and most successful in the nation.  He was instrumental in the founding of the NC Biosciences Organization, now NCBIO, ...read more
    Categories: General News Article, Press Release
    Thursday, February 18, 2021
    On Wednesday, Feb. 17, LaunchBio hosted a webinar discussing diversity in life science venture capitalism.    According to a new report, “Diversity and Inclusion in the VC Industry,” conducted by Deloitte and the National Venture Capital Association, only 15% of women, 15% of Asian and Pacific Islanders, of 3% African Americans and 3% of Latinos reach the partner level at venture capital ...read more
    Categories: General News Article
    Friday, February 12, 2021
    Governor Roy Cooper announced that Machelle Sanders, current secretary of the NC Department of Administration, will now serve as secretary of the Department of Commerce. She is a former member of the NCBIO Board of Directors. “Machelle has been an outstanding leader in this administration, and I am grateful that she is willing to take on this new role and continue to serve our great state,” Gov. ...read more
    Categories: General News Article
    Tuesday, February 02, 2021
    NCBIO member companies with 5 to 50 employees can get ACA-compliant, stable health-care coverage through BIO Business Solutions.   BIO is offering a group health-care solution administered by Mercer and underwritten by UnitedHealthcare at very competitive rates. Mercer provides support for both employers and employees, who can enroll with just a few clicks on a website. (Download Mercer ...read more
    Categories: General News Article
    Thursday, January 28, 2021
    The Board of Directors of the NCBIO voted unanimously Thursday, Jan. 28, to accept three new members to NC Biosciences Organization: mdgroup, Serepta Therapeutics and Xilis, Inc. London-based mdgroupis a leading global provider of personalized clinical study services on a mission to revolutionize the clinical research industry by making life better for patients taking part in clinical trials.The ...read more
    Categories: General News Article
    Wednesday, January 27, 2021
    The National Cancer Institute is eager to support and collaborate with innovative scientists and small companies and has two relatively new programs in place to support them, according to NCI representatives presenting during a Jan. 26 webinar hosted by BIO.Director Michael Weingarten and Program DirectorNancy Kamei of the NCI’s SBIR Development Center shared information about the NCI’s efforts to ...read more
    Categories: General News Article
    Tuesday, January 12, 2021
    The American Life Sciences Innovation Council awarded Rep. Richard Hudson (R-N.C.) the 2020 Champion of Health Care Innovation Award in an online presentation held Tuesday, Jan. 12, 2021.  The award recognizes Hudson's past and current efforts in Congress and in North Carolina to protect and nurture the important policies that position America as the world’s leading force in the innovative life ...read more
    Categories: General News Article
    Wednesday, December 16, 2020
    The American Life Sciences Innovation Council awarded Sen. Thom Tillis (R-N.C.) the 2020 Champion of Health Care Innovation Award in an online presentation held Wednesday, Dec. 16, 2020.  The award recognizes Tillis' past and current efforts in Congress and in North Carolina to protect and nurture the important policies that position America as the world’s leading force in the innovative life ...read more
    Categories: General News Article
    Wednesday, December 02, 2020
    NCBIO has named David Etchison as its new communications director. Etchison has more than 25 years of experience in communications, public relations and marketing. He served as director of communications for the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill for 15 years and most recently ran email marketing for UNC-TV.  Etchison succeeds Brenda Summers, Ed.D., ...read more
    Categories: General News Article
    Wednesday, November 25, 2020
    A new executive order from the Trump administration that slashes Medicare payments to hospitals and physicians for certain medicines will hurt patients’ access to care and financially stress already overburdened hospitals and innovation-based pharmaceutical companies, according to NCBIO, the NC Biosciences Organization.   On Nov. 20, President Donald Trump announced an interim final rule with ...read more
    Categories: Policy, General News Article
    Thursday, November 19, 2020
    A COVID-resilient environment and clinical trials was the topic of discussion at a virtual forum hosted by NCBIO November 19.  The concept of virtual or decentralized trials has been around for a while, but COVID-19 forced companies and the FDA to act. Biopharma, regulatory and CRO representatives shared their perspectives on decentralized trials, their challenges and limitations, and on COVID-19 ...read more
    Categories: General News Article
    Thursday, November 12, 2020
    DURHAM, N.C. — Neal Fowler, CEO of Liquidia Technologies, has been named the new chairman of the NCBIO Board of Directors, and five new members have joined the board. New officers and the 2020-21 executive committee were elected at the board meeting Thursday, November 12.   “We are very pleased that Neal has agreed to serve as our board chair,” said Sam Taylor, president of NCBIO, the North ...read more
    Categories: General News Article
    Wednesday, October 28, 2020
    Single-use supply chain strategy, moving to an electronic quality management system and applying AI and machine learning to microscopy were the topics discussed during the Virtual BIO Business Solutions Spotlight webinar presented by the NC Biosciences Organization for its members Wednesday, Oct. 28. Timothy Korwan, director, new product innovation for Avantor Fluid Handling Solutions, took ...read more
    Categories: General News Article
    Monday, October 05, 2020
    Four days of sessions on elections, policies, COVID-19 and more comprised the 2020 NCBIO Annual Meeting held Sept. 29 to Oct. 2.  “We are living through extraordinary challenges,” BIO CEO  Dr. Michelle McMurry-Heath said during the closing session of NCBIO Annual Meeting. “I  hope it is a turning point in the public’s understanding of why science matters. Biotech and science are the catalysts ...read more
    Categories: General News Article
    Friday, October 02, 2020
    The Biotechnology Innovation Organization awarded Roy Cooper, governor of North Carolina, its 2020 Governor of the Year Award. Cooper was presented the award virtually at NCBIO’s 2020 Annual Meeting.   BIO’s annual award recognizes governors for leadership in public service, commitment to public health, and dedication to advancing biotechnology in their state.   “Innovations in life sciences ...read more
    Categories: General News Article
  • NCBIO Events

  • Latest Tweets